Valli M B, Bertolini L, Manzin A, Clementi M, Carloni G
Istituto di Medicina Sperimentale, Rome, Italy.
Res Virol. 1998 Sep-Oct;149(5):331-3. doi: 10.1016/s0923-2516(99)89015-3.
We previously demonstrated that the human lymphoblastoid B-cell line (LCL) TOFE, derived from normal human bone marrow, is permissive to HCV infection. In this report we developed an in vitro HCV adsorption-inhibition assay based on TOFE cells, to reveal the presence of neutralizing antibodies in sera from acutely infected patients.
我们先前证明，源自正常人骨髓的人淋巴母细胞B细胞系（LCL）TOFE可被丙型肝炎病毒（HCV）感染。在本报告中，我们基于TOFE细胞开发了一种体外HCV吸附抑制试验，以揭示急性感染患者血清中中和抗体的存在。
